Search This Blog

Wednesday, November 13, 2019

Milestone Pharmaceuticals EPS misses by $0.06

Milestone Pharmaceuticals (NASDAQ:MIST): Q3 GAAP EPS of -$0.52 misses by $0.06.
Cash, Cash Equivalents and Short-term Investments of $136.5M.
Press Release
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)